Compound Sodium Alginate Double Action Chewable Tablet Symptomatic Relief Study

NCT01869491 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1107

Enrollment

INDUSTRY

Sponsor class

Conditions

Gastroesophageal Reflux Disease
Dyspepsia

Interventions

DRUG: Compound Sodium Alginate Double Action Chewable Tablets
DRUG: Matching placebo tablets

Sponsor

Reckitt Benckiser Healthcare (UK) Limited